News and Events

EINDHOVEN, the Netherlands — August 27, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will host a webcast to discuss its Half Year 2024 business highlights.

EINDHOVEN, the Netherlands — August 5, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today reaffirms its 2024 strategic priorities and releases its unaudited Q2 financial highlights.

EINDHOVEN, the Netherlands — July 17, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), recently published its Annual Sustainability Summary for the full year 2023.

EINDHOVEN, the Netherlands — July 9, 2024 — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announcesa publication in Neuromodulation: Technology at the Neural Interface,summarizing effective stimulation parameters from the Up-LIFT and LIFT Home studies and providing a decision-making framework for clinical implementation of ONWARD ARC-EX Therapy created by study investigators.